European Multiple Sclerosis Consortium to use Voxeleron’s Orion for OCT Image Analysis
Orion, Voxeleron’s device-independent, optical coherence tomography (OCT) image analysis platform will look for central nervous system damage.
Voxeleron is excited to announce their collaborative role in the Sys4MS (Systems for Multiple Sclerosis) multi-center research initiative aimed at developing new tools for personalized management of patients with MS and other complex diseases. Sys4MS focuses on five specific areas: genomics, proteomics, cytomics, imaging and phenotype. The imaging portion, run from the Charité - Universitätsmedizin Berlin’s NeuroCure Clinical Research Center, will use OrionTM to analyze OCT images and help quantify damage to the central nervous system.
“Analyzing all scans with the same software is especially important for us,” said Dr. Alexander Brandt, M.D., the head of the Neurodiagnostics Laboratory at Charité - Universitätsmedizin Berlin’s and the leader of the image analysis effort. “It considerably eases our reading workflow. We are very glad that Voxeleron has provided us with this solution and hope it will support new and useful findings.”
Voxeleron LLC is based in Pleasanton, CA, and was co-founded in 2010 by Daniel Russakoff and Jonathan Oakley to develop state-of-the-art software in the fields of artificial intelligence and computer vision. Voxeleron was the first to develop and commercially release platform-independent OCT analysis software in support of clinical and pharmaceutical research. We have an extensive intellectual property portfolio and a mission to be the leader in delivering advanced image analysis solutions for applications in medicine, biology, and beyond. For more information, please contact Voxeleron at contact(at)voxeleron(dot)com. Orion, Voxeleron’s device-independent, optical coherence tomography (OCT) image analysis platform will look for central nervous system damage.